News Chosa Oncology AB

Equities

CHOSA

SE0007784319

End-of-day quote NORDIC GROWTH MARKET Other stock markets 06:00:00 2024-01-31 pm EST			5-day change	1st Jan Change
0.53 ^SEK	+51.43%		-.--%	-6.03%

Mar. 28	Chosa Oncology Names CFO, Chief Commercial Officer	MT
Mar. 28	CHOSA Oncology AB Announces Chief Financial Officer Changes	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Chosa Oncology Names CFO, Chief Commercial Officer	Mar. 28	MT
CHOSA Oncology AB Announces Chief Financial Officer Changes	Mar. 28	CI
CHOSA Oncology Appoints Claus Frisenberg Pedersen as Chief Commercial Officer	Mar. 28	CI
Chosa Oncology AB Postpones Publication of Interim Report for the Second Quarter of 2023	23-08-27	CI
CHOSA Oncology AB Publishes Results from Clinical Phase 2 Trial of Liposomal Formulation in Breast Cancer, Using Predictive Marker for Cisplatin	23-06-03	CI
Chosa Oncology AB Announces Board Changes	23-05-26	CI
CHOSA Oncology AB Presents Clinical Phase 2 Results of LiPlaCis and its Drug Response Predictor Test at ASCO 2023	23-05-25	CI
CHOSA Oncology AB announces approved re-listing memorandum	23-05-03	AQ
CHOSA Oncology AB payback of convertible loan in process, update	23-04-21	AQ
CHOSA Oncology AB payback of convertible loan in process - update	23-04-20	AQ
CHOSA Oncology AB initiates payment of last portion of loan given to RhoVac AB	23-04-10	AQ
CHOSA Oncology AB initiates payment of last portion of loan given to RhoVac AB	23-04-08	AQ
RhoVac AB will Change its Name to CHOSA Oncology AB	23-02-15	CI
RhoVac AB has Changed its Name to CHOSA Oncology AB	23-02-10	CI
RhoVac AB (under name change to Chosa Oncology AB) has completed the acquisition of Chosa ApS and a new board and CEO have taken office	23-01-18	AQ
Rhovac AB Announces CEO Changes	23-01-18	CI
RhoVac AB Announces Board Changes	23-01-18	CI
Chosa ApS completed the acquisition of RhoVac AB from M2 Asset Management AB and others in a reverse merger transaction.	23-01-17	CI
RhoVac's co-founder Anders Ljungqvist has passed away	22-12-28	AQ
RhoVac AB conducts conditional reverse takeover of Chosa ApS	22-12-05	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Chosa Oncology AB

Equities

CHOSA

SE0007784319

Summary

Filters